MUTE RECEIVES MAJOR REGULATORY APPROVALS
MUTE RECEIVES MAJOR REGULATORY APPROVALS 3 December 2014 Melbourne technology firm, Rhinomed (ASX:RNO) is pleased to announce that it has successfully completed the testing and technical documentation that has enabled its new novel snoring and sleep quality product – Mute™ to gain acceptance with the US Food and Drug Administration(FDA), European authority (CE Mark) and … Read more